Evidence map›Paper›PMID 21931239›Full record

ArticleJournal of empirical research on human research ethics : JERHRE2011

Screening for understanding of research in the inpatient psychiatry setting.

Norval J Hickman, Judith J Prochaska, Laura B Dunn

Registry-linked trialAbstract read
In one paragraph

Article in Journal of empirical research on human research ethics : JERHRE, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03809897 (An Effectiveness and Safety Study of Varenicline for Smoking Cessation in Hospitalized Patients With Psychiatric Disorders), which is not on this map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03809897 phase4withdrawnnot on this mapstarted 2019, after this paper: background citation

An Effectiveness and Safety Study of Varenicline for Smoking Cessation in Hospitalized Patients With Psychiatric Disorders

TypeinterventionalSponsorHospital Universitari Vall d'Hebron Research InstituteRan2019 to 2020Enrolled0ConditionsTobacco Use Cessation, Psychiatric DisordersArmsVarenicline, Nicotine patch
3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 15 citations in OpenAlex.

  1. Trial
  2. Treating Tobacco Dependence at the Intersection of Diversity, Poverty, and Mental Illness: A Randomized Feasibility and Replication Trial.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2015
    Trial
  3. Multiple risk-behavior profiles of smokers with serious mental illness and motivation for change.Health psychology : official journal of the Division of Health Psychology, American Psychological Association · 2014
    Trial
  4. Trial
  5. Trial
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Norval J HickmanTreatment Research Center in the Department of Psychiatry, University of California-San Francisco, 401 Parnassus Avenue, San Francisco, CA 94143, USA. Norval.Hickman@ucsf.edu
Judith J Prochaska
Laura B Dunn
University of California, San Francisco · US

Funding

TREATMENTS FOR COMPLEX PATIENTS IN NEW SETTINGSP50DA009253 · NIDA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GUYDISH, JOSEPH R · 1994 to 2014
$28.2M
Substance Use Disorders Treatment/Services Research Training ProgramT32DA007250 · NIDA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Derek D Satre, Janice Y Tsoh · 1991 to 2026
$7.4M
Proxy Decision Making for Alzheimer Disease ResearchR01AG027986 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI DUNN, LAURA B. · 2007 to 2010
$1.4M
Treating Tobacco Dependence in Inpatient PsychiatryK23DA018691 · NIDA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI PROCHASKA, JUDITH J. · 2005 to 2009
$769k
NIA NIH HHS R01 AG027986NIA NIH HHS R01AG027986NIDA NIH HHS K23 DA018691NIDA NIH HHS K23DA018691NIDA NIH HHS P50 DA009253NIDA NIH HHS P50DA09253NIDA NIH HHS T32 DA007250NIDA NIH HHS T32DA007250
6 · The paper itself

Abstract

People with mental illness constitute a substantial proportion of smokers and an important population for smoking cessation research. Obtaining informed consent in this population is a critical ethical endeavor. We examined performance on a three-item instrument (3Q) designed to screen for understanding of several key elements of research: study purpose, risks, and benefits. Patients were clinically diagnosed with primary unipolar depression (n = 40), a primary psychotic disorder (n = 32), both mood and psychotic disorders (n = 17), and primary bipolar disorder (n = 14). Among an ethnically diverse sample of 124 psychiatric inpatients approached for a smoking cessation trial, 107 (86%) performed adequately on the 3Q (i.e., obtained a score of at least 3 out of a possible 6). Patients were better able to identify the study risks and benefits than to describe the study purpose. The 3Q appears to be a useful tool for researchers working with vulnerable psychiatric patients.

Indexed as

ComprehensionEthics, ResearchMental DisordersSmoking CessationAdultClinical Trials as TopicFemaleHumansInformed ConsentInpatientsMaleMiddle AgedPatient SatisfactionRiskSmokingSurveys and Questionnaires

Identifiers

PMID21931239
PMCPMC3357117
OpenAlexW2019945453

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.